TrialHeadache2022

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.

Miguel J A Láinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.